Mes-Masson AM - Search Results

1

Genomic analysis of low-grade serous ovarian carcinoma to identify key drivers and therapeutic vulnerabilities.

Cheasley D, Nigam A, Zethoven M, Hunter S, Etemadmoghadam D, Semple T, Allan P, Carey MS, Fernandez ML, Dawson A, Köbel M, Huntsman DG, Le Page C, Mes-Masson AM, Provencher D, Hacker N, Gao Y, Bowtell D, deFazio A, Gorringe KL, Campbell IG. Cheasley D, et al. J Pathol. 2021 Jan;253(1):41-54. doi: 10.1002/path.5545. Epub 2020 Oct 28. J Pathol. 2021. PMID: 32901952

2

Primary cultures of normal and tumoral human ovarian epithelium: a powerful tool for basic molecular studies.

Lounis H, Provencher D, Godbout C, Fink D, Milot MJ, Mes-Masson AM. Lounis H, et al. Exp Cell Res. 1994 Dec;215(2):303-9. doi: 10.1006/excr.1994.1346. Exp Cell Res. 1994. PMID: 7526992

3

Absence of human papillomavirus sequences in ovarian pathologies.

Trottier AM, Provencher D, Mes-Masson AM, Vauclair R, Coutlée F. Trottier AM, et al. J Clin Microbiol. 1995 Apr;33(4):1011-3. doi: 10.1128/jcm.33.4.1011-1013.1995. J Clin Microbiol. 1995. PMID: 7790425 Free PMC article.

4

Discordance in p53 mutations when comparing ascites and solid tumors from patients with serous ovarian cancer.

Provencher DM, Lounis H, Fink D, Drouin P, Mes-Masson AM. Provencher DM, et al. Tumour Biol. 1997;18(3):167-74. doi: 10.1159/000218027. Tumour Biol. 1997. PMID: 9143413

5

Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families.

Tonin PN, Mes-Masson AM, Futreal PA, Morgan K, Mahon M, Foulkes WD, Cole DE, Provencher D, Ghadirian P, Narod SA. Tonin PN, et al. Am J Hum Genet. 1998 Nov;63(5):1341-51. doi: 10.1086/302099. Am J Hum Genet. 1998. PMID: 9792861 Free PMC article.

6

Mapping of chromosome 3p deletions in human epithelial ovarian tumors.

Lounis H, Mes-Masson AM, Dion F, Bradley WE, Seymour RJ, Provencher D, Tonin PN. Lounis H, et al. Oncogene. 1998 Nov 5;17(18):2359-65. doi: 10.1038/sj.onc.1202152. Oncogene. 1998. PMID: 9811467

7

Expression of FHIT in primary cultures of human epithelial ovarian tumors and malignant ovarian ascites.

Manning AP, Mes-Masson AM, Seymour RJ, Tetrault M, Provencher DM, Tonin PN. Manning AP, et al. Mol Carcinog. 1999 Mar;24(3):218-25. doi: 10.1002/(sici)1098-2744(199903)24:3<218::aid-mc8>3.0.co;2-a. Mol Carcinog. 1999. PMID: 10204806

8

Founder BRCA1 and BRCA2 mutations in French Canadian ovarian cancer cases unselected for family history.

Tonin PN, Mes-Masson AM, Narod SA, Ghadirian P, Provencher D. Tonin PN, et al. Clin Genet. 1999 May;55(5):318-24. doi: 10.1034/j.1399-0004.1999.550504.x. Clin Genet. 1999. PMID: 10422801

9

Allelotyping defines minimal imbalance at chromosomal region 17q25 in non-serous epithelial ovarian cancers.

Dion F, Mes-Masson AM, Seymour RJ, Provencher D, Tonin PN. Dion F, et al. Oncogene. 2000 Mar 9;19(11):1466-72. doi: 10.1038/sj.onc.1203463. Oncogene. 2000. PMID: 10723138

10

Trisomy of chromosome 10 in two cases of ovarian carcinoma.

Wang J, Mes-Masson AM, Tonin PN, Provencher D, Eydoux P. Wang J, et al. Cancer Genet Cytogenet. 2000 Apr 1;118(1):65-8. doi: 10.1016/s0165-4608(99)00170-3. Cancer Genet Cytogenet. 2000. PMID: 10731594

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

327 results

Search Page